HHS to invest $3 billion for antiviral pills against COVID-19

The Biden administration will invest $3.2 billion to foster the development of antiviral pills to help fight against COVID-19, the Health and Human Services department announced Thursday, with hopes the medication becomes available to the public as soon as the end of this year.

The big picture: Researchers had tested existing antivirals like remdesivir in hospitals on patients with severe COVID-19, but they produced underwhelming results and little to no benefit.

The Food and Drug Administration has given emergency authorization for three monoclonal antibody drug treatment for early COVID infections.
...